Preface |
|
xiii | |
Acknowledgments |
|
xv | |
|
|
1 | (14) |
|
1.1 Nanomedicine: A Global Vision |
|
|
1 | (2) |
|
1.2 The Nanotechnology Revolution: Realization of Asimov's Fiction |
|
|
3 | (4) |
|
1.3 Nanomedicine: A New Era in Personalized Medicine |
|
|
7 | (2) |
|
1.4 Nanomedicine: A Promise or Reality? |
|
|
9 | (1) |
|
1.5 A New Frontier: Multidisciplinary Challenges and Opportunities |
|
|
10 | (2) |
|
1.6 Scope of the Book: Multidisciplinary Education, Training, and Research |
|
|
12 | (1) |
|
|
13 | (2) |
|
|
15 | (36) |
|
2.1 Introductory Concepts |
|
|
16 | (2) |
|
|
18 | (5) |
|
2.3 Various Types of Cells |
|
|
23 | (2) |
|
2.4 Biochemical Makeup of Cells |
|
|
25 | (4) |
|
2.5 Other Important Cellular Components |
|
|
29 | (1) |
|
|
30 | (7) |
|
2.7 Organization of Cells into Tissues |
|
|
37 | (2) |
|
2.8 Types of Tissues and Their Functions |
|
|
39 | (1) |
|
2.9 Various Organs and Organ Systems in the Body |
|
|
40 | (5) |
|
|
45 | (1) |
|
|
46 | (2) |
|
|
48 | (1) |
|
|
49 | (2) |
|
|
51 | (26) |
|
3.1 Nanocarriers: Delivering Payloads to Needed Sites |
|
|
52 | (1) |
|
3.2 The Various Nanoformulations for Nanomedicine |
|
|
53 | (2) |
|
3.3 Viruses as Nanocarriers |
|
|
55 | (1) |
|
3.4 Polymeric Nanocarriers |
|
|
56 | (2) |
|
3.5 Lipid-Based Nanocarriers |
|
|
58 | (1) |
|
|
59 | (2) |
|
3.7 Carbon Nanostructures |
|
|
61 | (2) |
|
3.8 Inorganic Nanoparticles |
|
|
63 | (2) |
|
|
65 | (1) |
|
|
66 | (2) |
|
|
68 | (1) |
|
3.12 New-Generation Nanocarriers |
|
|
69 | (1) |
|
|
70 | (2) |
|
|
72 | (1) |
|
|
73 | (4) |
|
4 Nanochemistry Of Nanocarriers |
|
|
77 | (26) |
|
4.1 Nanochemistry and Nanomedicine |
|
|
78 | (1) |
|
|
78 | (5) |
|
|
79 | (1) |
|
4.2.2 Dip-Pen Nanolithography |
|
|
79 | (2) |
|
|
81 | (1) |
|
|
81 | (2) |
|
|
83 | (9) |
|
|
83 | (3) |
|
4.3.2 Microemulsion Chemistry |
|
|
86 | (1) |
|
4.3.3 Hot-Colloidal Synthesis |
|
|
87 | (3) |
|
4.3.4 Seed-Mediated Synthesis of Anisotropic Metallic Nanostructures |
|
|
90 | (1) |
|
4.3.5 Reprecipitation Method |
|
|
90 | (2) |
|
4.4 Combination of Bottom-Up and Top-Down Approaches |
|
|
92 | (1) |
|
4.5 Nanoparticle Surface Modification |
|
|
93 | (2) |
|
4.6 Functionalization and Bioconjugation |
|
|
95 | (2) |
|
|
97 | (2) |
|
|
99 | (1) |
|
|
100 | (3) |
|
5 Multifunctionalities For Diagnostics And Therapy |
|
|
103 | (32) |
|
5.1 The Various Functionalities |
|
|
104 | (1) |
|
5.2 Optical Functionalities |
|
|
105 | (5) |
|
|
110 | (6) |
|
5.4 Magnetic Functionality |
|
|
116 | (4) |
|
5.5 Thermal Functionality |
|
|
120 | (1) |
|
5.6 Radioactive Functionality |
|
|
121 | (3) |
|
5.7 Biological Functionality |
|
|
124 | (1) |
|
|
125 | (3) |
|
|
128 | (2) |
|
|
130 | (1) |
|
|
131 | (4) |
|
6 Crossing The Biological Barriers |
|
|
135 | (14) |
|
6.1 Various Delivery Pathways |
|
|
135 | (2) |
|
6.2 Various Biological Barriers |
|
|
137 | (3) |
|
6.3 Stealth Nanoparticles |
|
|
140 | (1) |
|
6.4 The Various In Vitro Barrier Models |
|
|
141 | (3) |
|
|
144 | (1) |
|
|
145 | (1) |
|
|
146 | (3) |
|
|
149 | (14) |
|
7.1 Biotargeting: Why We Need It |
|
|
149 | (1) |
|
7.2 Targeted Biological Sites |
|
|
150 | (1) |
|
|
151 | (2) |
|
|
153 | (2) |
|
|
155 | (4) |
|
|
159 | (1) |
|
|
160 | (1) |
|
|
161 | (2) |
|
8 Multimodal Biomedical Imaging |
|
|
163 | (44) |
|
8.1 Biomedical Imaging Techniques |
|
|
164 | (6) |
|
|
170 | (15) |
|
8.2.1 Fluorescence Microscopy |
|
|
170 | (2) |
|
8.2.2 Quantitative FRET Microscopy |
|
|
172 | (3) |
|
8.2.3 Technical Challenges for In Vitro Imaging |
|
|
175 | (2) |
|
8.2.4 In Vivo Optical Imaging |
|
|
177 | (1) |
|
8.2.5 Optical Coherence Tomography |
|
|
177 | (4) |
|
8.2.6 Super-Resolution Fluorescence Microscopy |
|
|
181 | (4) |
|
8.3 Magnetic Resonance Imaging |
|
|
185 | (3) |
|
|
188 | (2) |
|
|
190 | (1) |
|
|
190 | (1) |
|
8.7 Photoacoustic Imaging |
|
|
191 | (1) |
|
|
192 | (1) |
|
|
193 | (7) |
|
|
200 | (1) |
|
|
201 | (6) |
|
|
207 | (46) |
|
9.1 Principles of Biosensing |
|
|
208 | (3) |
|
|
211 | (17) |
|
9.2.1 Fluorescencs Sensors |
|
|
211 | (7) |
|
|
218 | (9) |
|
9.2.3 Photonic Crystal Sensors |
|
|
227 | (1) |
|
|
228 | (6) |
|
9.4 Electrical Biosensing |
|
|
234 | (2) |
|
9.5 Electrochemical Biosensing |
|
|
236 | (2) |
|
9.6 Electrochemiluminescence Biosensing |
|
|
238 | (1) |
|
9.7 In Vivo Bioelectronic Sensors |
|
|
239 | (2) |
|
|
241 | (4) |
|
|
245 | (2) |
|
|
247 | (6) |
|
10 High-Throughput Multiplexed Diagnostics |
|
|
253 | (38) |
|
10.1 Comprehensive Diagnostic Strategy |
|
|
254 | (1) |
|
|
255 | (9) |
|
10.3 Enzyme-Linked Immunosorbent Assay (ELISA) |
|
|
264 | (5) |
|
10.4 Microarrays Technology |
|
|
269 | (8) |
|
10.5 Suspension Bead Assay |
|
|
277 | (4) |
|
|
281 | (4) |
|
|
285 | (1) |
|
|
286 | (5) |
|
|
291 | (14) |
|
11.1 Nanopharmacotherapy: An Overview |
|
|
292 | (2) |
|
11.2 Modes of Nanoformulation for Nanopharmacotherapy |
|
|
294 | (2) |
|
|
296 | (1) |
|
|
297 | (1) |
|
|
298 | (1) |
|
11.6 Controlled Release by External Activation |
|
|
299 | (1) |
|
|
300 | (2) |
|
|
302 | (1) |
|
|
303 | (2) |
|
12 The Human Circulatory System And Theranostics |
|
|
305 | (26) |
|
12.1 Blood Fluidics and Cardiovascular System |
|
|
306 | (3) |
|
12.2 Circulatory-System-Based Disease Profiling |
|
|
309 | (3) |
|
12.3 Methods to Monitor Blood Flow |
|
|
312 | (6) |
|
12.4 Therapeutic Approaches Utilizing Manipulation of Blood Flow |
|
|
318 | (2) |
|
|
320 | (2) |
|
12.6 Lymphatic Drug Delivery |
|
|
322 | (1) |
|
|
322 | (4) |
|
|
326 | (1) |
|
|
327 | (4) |
|
13 Nanotechnology For Cancer |
|
|
331 | (40) |
|
13.1 Benefits of Cancer Nanotechnology |
|
|
332 | (3) |
|
|
335 | (4) |
|
|
339 | (1) |
|
13.4 Photodynamic Therapy |
|
|
340 | (9) |
|
|
349 | (4) |
|
13.6 Photothermal Therapy |
|
|
353 | (4) |
|
13.7 Neutron Capture Therapy |
|
|
357 | (2) |
|
13.8 Circulating Tumor Cells |
|
|
359 | (1) |
|
13.9 NCI Alliance for Cancer Nanotechnology |
|
|
360 | (1) |
|
|
360 | (2) |
|
|
362 | (2) |
|
|
364 | (7) |
|
|
371 | (22) |
|
14.1 The Principles, Steps, and Impact of Gene Therapy |
|
|
372 | (2) |
|
14.2 Methods of Gene Delivery |
|
|
374 | (7) |
|
14.3 Gene Augmentation Therapy |
|
|
381 | (1) |
|
14.4 Gene Silencing Therapy |
|
|
381 | (3) |
|
14.5 Indirect Gene Therapy Modulating Innate Immune Response |
|
|
384 | (1) |
|
14.6 Transmucosal Gene Delivery |
|
|
385 | (1) |
|
|
386 | (2) |
|
|
388 | (2) |
|
|
390 | (3) |
|
15 Nanotechnology For Infectious Diseases |
|
|
393 | (40) |
|
15.1 Pathogen Infections and Nanoparticle-Based Approaches |
|
|
394 | (7) |
|
|
401 | (7) |
|
|
402 | (2) |
|
15.2.2 Vaccines and Antimicrobial Drugs |
|
|
404 | (1) |
|
|
405 | (3) |
|
|
408 | (2) |
|
|
408 | (1) |
|
|
409 | (1) |
|
|
409 | (1) |
|
|
410 | (6) |
|
|
410 | (2) |
|
|
412 | (1) |
|
|
412 | (4) |
|
|
416 | (6) |
|
|
418 | (2) |
|
|
420 | (2) |
|
|
422 | (2) |
|
|
424 | (2) |
|
|
426 | (7) |
|
|
433 | (14) |
|
16.1 Rejuvenation Therapy: Fantasy or Reality? |
|
|
433 | (3) |
|
16.2 Free Radical Scavenging |
|
|
436 | (3) |
|
|
439 | (2) |
|
|
441 | (1) |
|
|
442 | (1) |
|
|
443 | (1) |
|
|
444 | (3) |
|
17 Stem Cell Biotechnology |
|
|
447 | (14) |
|
17.1 Stem Cell Biotechnology: Overview |
|
|
448 | (1) |
|
|
449 | (3) |
|
|
452 | (1) |
|
17.4 Somatic Cell Transdifferentiation |
|
|
453 | (1) |
|
|
454 | (1) |
|
|
454 | (2) |
|
|
456 | (1) |
|
|
456 | (1) |
|
|
457 | (4) |
|
|
461 | (26) |
|
18.1 Tissue Engineering: Overview |
|
|
462 | (2) |
|
|
464 | (3) |
|
18.3 Nanotechnology in Tissue Engineering |
|
|
467 | (5) |
|
18.4 Nanofibers for Tissue Engineering |
|
|
472 | (1) |
|
18.5 Nanoparticle Delivery of Biomolecules |
|
|
473 | (1) |
|
18.6 Magnetically Assisted Tissue Engineering |
|
|
474 | (1) |
|
18.7 Tissue/Organ Printing |
|
|
475 | (2) |
|
|
477 | (2) |
|
|
479 | (3) |
|
|
482 | (2) |
|
|
484 | (3) |
|
19 Nanodermatology And Nanocosmetics |
|
|
487 | (16) |
|
19.1 Delivery Through Skin |
|
|
487 | (1) |
|
19.2 Skin Care and Nanotechnology |
|
|
488 | (3) |
|
19.3 Various Nanoparticles for Dermatology and Cosmetics |
|
|
491 | (1) |
|
|
492 | (2) |
|
|
494 | (3) |
|
19.6 Nanotoxicology of the Skin |
|
|
497 | (1) |
|
|
497 | (1) |
|
|
498 | (1) |
|
|
499 | (4) |
|
|
503 | (26) |
|
20.1 Nanotechnology for Dental Care |
|
|
504 | (3) |
|
20.2 Nanoparticles for Preventive Dentistry |
|
|
507 | (2) |
|
20.3 Nanomaterials for Restorative Dentistry |
|
|
509 | (7) |
|
20.4 Regenerative Dentistry |
|
|
516 | (3) |
|
20.5 Nanoparticle-Enhanced Dental Imaging and Oral Diagnostics |
|
|
519 | (3) |
|
20.6 Nanorobotics for Dentistry |
|
|
522 | (1) |
|
|
522 | (2) |
|
|
524 | (1) |
|
|
525 | (4) |
|
|
529 | (26) |
|
21.1 Toxicity of Nanoparticles |
|
|
529 | (4) |
|
|
533 | (2) |
|
21.3 In Vitro Cytotoxicity Assays |
|
|
535 | (4) |
|
|
539 | (3) |
|
21.5 In Vivo Toxicity Evaluation |
|
|
542 | (1) |
|
21.6 Nanotoxicity Studies on Selected Nanoparticles |
|
|
542 | (5) |
|
|
547 | (3) |
|
|
550 | (1) |
|
|
551 | (4) |
Index |
|
555 | |